硝子体内(IVT)注射剤の世界市場インサイト・予測(~2025年)

QYResearchが発行した調査報告書(QYR20FB12458)
◆英語タイトル:Global Intravitreal (IVT) Injectables Market Insights, Forecast to 2025
◆商品コード:QYR20FB12458
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年12月2日(※2024年版があります。お問い合わせください。)
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、世界の硝子体内(IVT)注射剤市場について調査・分析し、以下の構成でお届け致します。硝子体内(IVT)注射剤の種類別には、抗VEGF、コルチコステロイド、抗生物質、抗ウイルス薬、抗真菌薬に、用途別には、病院薬局、小売薬局、ドラッグストア、通信販売薬局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別硝子体内(IVT)注射剤売上データ
・地域別硝子体内(IVT)注射剤市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別硝子体内(IVT)注射剤市場規模:抗VEGF、コルチコステロイド、抗生物質、抗ウイルス薬、抗真菌薬
・用途別硝子体内(IVT)注射剤市場規模:病院薬局、小売薬局、ドラッグストア、通信販売薬局、その他
・主要メーカーの企業情報:Regeneron Pharmaceuticals、Bausch & Lomb、Novartis、Allergan、Alimera Sciences、ThromboGenics、Bristol-Myers Squibb
・硝子体内(IVT)注射剤の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...
【レポートの概要】

Intravitreal drug delivery has become a popular method of treatment of many retinal diseases, commonly including AMD, Diabetic Retinopathy, and Retinal Vein Occlusions.Rising demand from Asia-Pacific region a major driver for the growth of the market.
The global Intravitreal (IVT) Injectables market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravitreal (IVT) Injectables market based on company, product type, end user and key regions.

This report studies the global market size of Intravitreal (IVT) Injectables in key regions like North America, Europe, China and Japan, focuses on the consumption of Intravitreal (IVT) Injectables in these regions.
This research report categorizes the global Intravitreal (IVT) Injectables market by top players/brands, region, type and end user. This report also studies the global Intravitreal (IVT) Injectables market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Regeneron Pharmaceuticals
Bausch & Lomb
Novartis
Allergan
Alimera Sciences
ThromboGenics
Bristol-Myers Squibb

Intravitreal (IVT) Injectables market size by Type
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals

Intravitreal (IVT) Injectables market size by Applications
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Others

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Intravitreal (IVT) Injectables market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Intravitreal (IVT) Injectables market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intravitreal (IVT) Injectables companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Intravitreal (IVT) Injectables submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Intravitreal (IVT) Injectables are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravitreal (IVT) Injectables market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Study Coverage
1.1 Intravitreal (IVT) Injectables Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Intravitreal (IVT) Injectables Market Size Growth Rate by Type
1.4.2 Anti-VEGF
1.4.3 Corticosteroids
1.4.4 Antibiotics
1.4.5 Antivirals
1.4.6 Antifungals
1.5 Market by Application
1.5.1 Global Intravitreal (IVT) Injectables Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 Mail Order Pharmacies
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Intravitreal (IVT) Injectables Market Size
2.1.1 Global Intravitreal (IVT) Injectables Revenue 2014-2025
2.1.2 Global Intravitreal (IVT) Injectables Sales 2014-2025
2.2 Intravitreal (IVT) Injectables Growth Rate by Regions
2.2.1 Global Intravitreal (IVT) Injectables Sales by Regions
2.2.2 Global Intravitreal (IVT) Injectables Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Intravitreal (IVT) Injectables Sales by Manufacturers
3.1.1 Intravitreal (IVT) Injectables Sales by Manufacturers
3.1.2 Intravitreal (IVT) Injectables Sales Market Share by Manufacturers
3.2 Intravitreal (IVT) Injectables Revenue by Manufacturers
3.2.1 Intravitreal (IVT) Injectables Revenue by Manufacturers (2014-2019)
3.2.2 Intravitreal (IVT) Injectables Revenue Share by Manufacturers (2014-2019)
3.3 Intravitreal (IVT) Injectables Price by Manufacturers
3.4 Intravitreal (IVT) Injectables Manufacturing Base Distribution, Product Types
3.4.1 Intravitreal (IVT) Injectables Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intravitreal (IVT) Injectables Product Type
3.4.3 Date of International Manufacturers Enter into Intravitreal (IVT) Injectables Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Intravitreal (IVT) Injectables Sales by Type
4.2 Global Intravitreal (IVT) Injectables Revenue by Type
4.3 Intravitreal (IVT) Injectables Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Intravitreal (IVT) Injectables Breakdown Data by Application

6 North America
6.1 North America Intravitreal (IVT) Injectables by Country
6.1.1 North America Intravitreal (IVT) Injectables Sales by Country
6.1.2 North America Intravitreal (IVT) Injectables Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Intravitreal (IVT) Injectables by Type
6.3 North America Intravitreal (IVT) Injectables by Application

7 Europe
7.1 Europe Intravitreal (IVT) Injectables by Country
7.1.1 Europe Intravitreal (IVT) Injectables Sales by Country
7.1.2 Europe Intravitreal (IVT) Injectables Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intravitreal (IVT) Injectables by Type
7.3 Europe Intravitreal (IVT) Injectables by Application

8 Asia Pacific
8.1 Asia Pacific Intravitreal (IVT) Injectables by Region
8.1.1 Asia Pacific Intravitreal (IVT) Injectables Sales by Region
8.1.2 Asia Pacific Intravitreal (IVT) Injectables Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Intravitreal (IVT) Injectables by Type
8.3 Asia Pacific Intravitreal (IVT) Injectables by Application

9 Central & South America
9.1 Central & South America Intravitreal (IVT) Injectables by Country
9.1.1 Central & South America Intravitreal (IVT) Injectables Sales by Country
9.1.2 Central & South America Intravitreal (IVT) Injectables Revenue by Country
9.1.3 Brazil
9.2 Central & South America Intravitreal (IVT) Injectables by Type
9.3 Central & South America Intravitreal (IVT) Injectables by Application

10 Middle East and Africa
10.1 Middle East and Africa Intravitreal (IVT) Injectables by Country
10.1.1 Middle East and Africa Intravitreal (IVT) Injectables Sales by Country
10.1.2 Middle East and Africa Intravitreal (IVT) Injectables Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Intravitreal (IVT) Injectables by Type
10.3 Middle East and Africa Intravitreal (IVT) Injectables by Application

11 Company Profiles
11.1 Regeneron Pharmaceuticals
11.1.1 Regeneron Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Products Offered
11.1.5 Regeneron Pharmaceuticals Recent Development
11.2 Bausch & Lomb
11.2.1 Bausch & Lomb Company Details
11.2.2 Company Business Overview
11.2.3 Bausch & Lomb Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bausch & Lomb Intravitreal (IVT) Injectables Products Offered
11.2.5 Bausch & Lomb Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Intravitreal (IVT) Injectables Products Offered
11.3.5 Novartis Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Company Business Overview
11.4.3 Allergan Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Allergan Intravitreal (IVT) Injectables Products Offered
11.4.5 Allergan Recent Development
11.5 Alimera Sciences
11.5.1 Alimera Sciences Company Details
11.5.2 Company Business Overview
11.5.3 Alimera Sciences Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Alimera Sciences Intravitreal (IVT) Injectables Products Offered
11.5.5 Alimera Sciences Recent Development
11.6 ThromboGenics
11.6.1 ThromboGenics Company Details
11.6.2 Company Business Overview
11.6.3 ThromboGenics Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.6.4 ThromboGenics Intravitreal (IVT) Injectables Products Offered
11.6.5 ThromboGenics Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Company Business Overview
11.7.3 Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Bristol-Myers Squibb Intravitreal (IVT) Injectables Products Offered
11.7.5 Bristol-Myers Squibb Recent Development

12 Future Forecast
12.1 Intravitreal (IVT) Injectables Market Forecast by Regions
12.1.1 Global Intravitreal (IVT) Injectables Sales Forecast by Regions 2019-2025
12.1.2 Global Intravitreal (IVT) Injectables Revenue Forecast by Regions 2019-2025
12.2 Intravitreal (IVT) Injectables Market Forecast by Type
12.2.1 Global Intravitreal (IVT) Injectables Sales Forecast by Type 2019-2025
12.2.2 Global Intravitreal (IVT) Injectables Revenue Forecast by Type 2019-2025
12.3 Intravitreal (IVT) Injectables Market Forecast by Application
12.4 North America Intravitreal (IVT) Injectables Forecast
12.5 Europe Intravitreal (IVT) Injectables Forecast
12.6 Asia Pacific Intravitreal (IVT) Injectables Forecast
12.7 Central & South America Intravitreal (IVT) Injectables Forecast
12.8 Middle East and Africa Intravitreal (IVT) Injectables Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intravitreal (IVT) Injectables Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Regeneron Pharmaceuticals、Bausch & Lomb、Novartis、Allergan、Alimera Sciences、ThromboGenics、Bristol-Myers Squibb

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 硝子体内(IVT)注射剤の世界市場インサイト・予測(~2025年)(Global Intravitreal (IVT) Injectables Market Insights, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。